Beyoglu, Diren

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2016 | 2014 | 2013

2016

Wang, Min; Keogh, Adrian; Treves, Susan; Idle, Jeffrey; Beyoglu, Diren (2016). The metabolomic profile of gamma-irradiated human hepatoma and muscle cells reveals metabolic changes consistent with the Warburg effect. PeerJ, 4, e1624. PeerJ, Ltd 10.7717/peerj.1624

2014

Beyoglu, Diren; Krausz, K. W.; Martin, Juliette; Maurhofer, Olivier; Dorow, J.; Ceglarek, U.; Gonzalez, F. J.; Dufour, Jean-François; Idle, Jeffrey (2014). Disruption of tumor suppressor gene Hint1 leads to remodeling of the lipid metabolic phenotype of mouse liver. Journal of lipid research, 55(11), pp. 2309-2319. American Society for Biochemistry and Molecular Biology ASBMB 10.1194/jlr.M050682

Beyoglu, Diren; Idle, Jeffrey (2014). Painting the liver with lasers: The future of liver histology? Hepatology, 59(3), pp. 757-760. Wiley Interscience 10.1002/hep.26734

Semmo, Nasser; Semmo, Nasser; Weber, Thomas; Idle, Jeffrey; Idle, Jeffrey; Beyoglu, Diren (2014). Metabolomics reveals that aldose reductase activity due to AKR1B10 is upregulated in hepatitis C virus infection. Journal of viral hepatitis, 22(7), pp. 617-624. Blackwell Science 10.1111/jvh.12376

Beyoglu, Diren; Idle, Jeffrey (2014). A history and overview of phenotypic variability in CYP2D6 activity. In: Baumann, Pierre (ed.) CYP2D6: Genetics, Pharmacology and Clinical Relevance (pp. 8-27). London: Future Medicine 10.2217/FMEB2013.13.97

2013

Cheng, Jie; Zhen, Yueying; Miksys, Sharon; Beyoglu, Diren; Krausz, Kristopher W.; Tyndale, Rachel F.; Yu, Aiming; Idle, Jeffrey R.; Gonzalez, Frank J. (2013). Potential role of CYP2D6 in the central nervous system. Xenobiotica, 43(11), pp. 973-984. Informa Healthcare 10.3109/00498254.2013.791410

Beyoglu, Diren; Imbeaud, Sandrine; Maurhofer, Olivier; Bioulac-Sage, Paulette; Zucman-Rossi, Jessica; Dufour, Jean-François; Idle, Jeffrey R. (2013). Tissue metabolomics of hepatocellular carcinoma: Tumor energy metabolism and the role of transcriptomic classification. Hepatology, 58(1), pp. 229-238. Wiley Interscience 10.1002/hep.26350

Beyoglu, Diren; Dufour, Jean-François; Idle, Jeffrey (February 2013). Lipid metabolomics in hepatocellular carcinoma (Unpublished). In: EASL Monothematic Conference. Luxembourg. Februar 2013.

Beyoglu, Diren; Idle, Jeffrey (2013). The metabolomic window into hepatobiliary disease. Journal of hepatology, 59(4), pp. 842-858. Elsevier 10.1016/j.jhep.2013.05.030

Beyoglu, Diren; Idle, Jeffrey (2013). Metabolomics and its potential in drug development. Biochemical pharmacology, 85(1), pp. 12-20. Elsevier 10.1016/j.bcp.2012.08.013

Provide Feedback